Nilatinib Maleate Tablets Combined With Capecitabine in the Treatment of HER2-positive Advanced Esophageal/Esophagogastric Junction/Gastric Adenocarcinoma With Brain Metastases
Clinical trial NCT06374888 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06374888
- Sponsor
- Convalife (Shanghai) Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-30
- Primary completion
- 2026-09-30
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.